help button home button Am J Pathol R & D Systems
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rodgers, K.
Right arrow Articles by Godson, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rodgers, K.
Right arrow Articles by Godson, C.
(American Journal of Pathology. 2005;167:683-694.)
© 2005 American Society for Investigative Pathology

Lipoxin A4 Modifies Platelet-Derived Growth Factor-Induced Profibrotic Gene Expression in Human Renal Mesangial Cells

Karen Rodgers, Blaithin McMahon, Derick Mitchell, Denise Sadlier and Catherine Godson

From the Department of Medicine and Therapeutics, The Conway Institute for Biomolecular and Biomedical Research, University College Dublin, Dublin; and The Dublin Molecular Medicine Centre, Dublin, Ireland

Lipoxins (LXs), endogenously produced eicosanoids, possess potent anti-inflammatory, proresolution bioactivities. We investigated the potential of LXA4 (1 to 10 nmol/L) to modify the effects of platelet-derived growth factor (PDGF)-induced gene expression in human renal mesangial cells (hMCs). Using oligonucleotide microarray analysis we profiled profibrotic cytokines and matrix-associated genes induced in response to PDGF. LXA4 modulated the expression of many PDGF-induced genes, including transforming growth factor-ß1, fibronectin, thrombospondin, matrix metalloproteinase 1, and several collagens. Analysis of both transcript and protein levels confirmed these findings. Because the activated glomerulus is frequently a source of injurious mediators that contribute to tubulointerstitial damage, we investigated the effect of hMC-secreted products on the integrity of renal proximal tubular epithelial cells using an in vitro model of progressive renal disease. Cell supernatant from PDGF-stimulated hMCs caused morphological and genetic changes in proximal tubular epithelial cells, consistent with a profibrotic phenotype. Interestingly, supernatant from cells pre-exposed to LXA4 and PDGF did not induce these effects. These results suggest a novel role for LXA4 as a potent modulator of matrix accumulation and profibrotic change and suggest a potential protective role in progressive renal disease.




This article has been cited by other articles:


Home page
 Pharmacol. Rev.Home page
R. D. Ye, F. Boulay, J. M. Wang, C. Dahlgren, C. Gerard, M. Parmentier, C. N. Serhan, and P. M. Murphy
International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the Formyl Peptide Receptor (FPR) Family
Pharmacol. Rev., June 1, 2009; 61(2): 119 - 161.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Cell Physiol.Home page
Y. Decker, G. McBean, and C. Godson
Lipoxin A4 inhibits IL-1{beta}-induced IL-8 and ICAM-1 expression in 1321N1 human astrocytoma cells
Am J Physiol Cell Physiol, June 1, 2009; 296(6): C1420 - C1427.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
V. Martins, S. S. Valenca, F. A. Farias-Filho, R. Molinaro, R. L. Simoes, T. P. T. Ferreira, P. M. R. e Silva, C. M. Hogaboam, S. L. Kunkel, I. M. Fierro, et al.
ATLa, an Aspirin-Triggered Lipoxin A4 Synthetic Analog, Prevents the Inflammatory and Fibrotic Effects of Bleomycin-Induced Pulmonary Fibrosis
J. Immunol., May 1, 2009; 182(9): 5374 - 5381.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
N. Baker, S. J. O'Meara, M. Scannell, P. Maderna, and C. Godson
Lipoxin A4: Anti-Inflammatory and Anti-Angiogenic Impact on Endothelial Cells
J. Immunol., March 15, 2009; 182(6): 3819 - 3826.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
M. B. Lowry, S. Lotinun, A. A. Leontovich, M. Zhang, A. Maran, K. L. Shogren, B. K. Palama, K. Marley, U. T. Iwaniec, and R. T. Turner
Osteitis Fibrosa Is Mediated by Platelet-Derived Growth Factor-A Via a Phosphoinositide 3-Kinase-Dependent Signaling Pathway in a Rat Model for Chronic Hyperparathyroidism
Endocrinology, November 1, 2008; 149(11): 5735 - 5746.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
D. Mitchell, S. J. O'Meara, A. Gaffney, J. K. G. Crean, B. T. Kinsella, and C. Godson
The Lipoxin A4 Receptor Is Coupled to SHP-2 Activation: IMPLICATIONS FOR REGULATION OF RECEPTOR TYROSINE KINASES
J. Biol. Chem., May 25, 2007; 282(21): 15606 - 15618.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
H.-J. Kim, B. C. Litzenburger, X. Cui, D. A. Delgado, B. C. Grabiner, X. Lin, M. T. Lewis, M. M. Gottardis, T. W. Wong, R. M. Attar, et al.
Constitutively Active Type I Insulin-Like Growth Factor Receptor Causes Transformation and Xenograft Growth of Immortalized Mammary Epithelial Cells and Is Accompanied by an Epithelial-to-Mesenchymal Transition Mediated by NF-{kappa}B and Snail
Mol. Cell. Biol., April 15, 2007; 27(8): 3165 - 3175.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
C. Bonnans, K. Fukunaga, M. A. Levy, and B. D. Levy
Lipoxin A4 Regulates Bronchial Epithelial Cell Responses to Acid Injury
Am. J. Pathol., April 1, 2006; 168(4): 1064 - 1072.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the American Society for Investigative Pathology.